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Madness: a brief history
By Roy Porter
Oxford University Press, Oxford, England,
and New York, USA, 2002.
ISBN 0 19 280266 6, price: £11.99 and US$ 22
Roy Porter’s final contribution to the
history of medicine, published shortly
before his death at 55, is more of an
executive summary than a history, even
a brief one. But it is a good read, full
of provocative insights. Somewhat
immodestly described by the author as
‘brief, bold, and unbiased’, the book
seeks to assess the credibility of main-
stream views of the history of psychiatry
as a steady march towards progress
and enlightenment. Though he draws
back from saying so outright, it is clear
that Porter sees only modest evidence
of either progress or enlightenment.
In spite of the title, this is not really
a history of madness but a history of
psychiatry — or rather of the faltering,
inconsistent, faddish and often hubristic
attempts to determine who is mad,
why, and what can be done about it. For
each epoch, Porter draws from the
ambient culture, expressed in poetry,
philosophy or literature, some of
the notions, ideologies or outright
prejudices that moulded the theory
of madness and the clinical responses
to it.
For Porter the history of the asylum
is emblematic of the instability of both
the theory and practice of psychiatry.
From the time of Bedlam in London
(originally called St Mary of Bethlehem,
then Bethlem Royal Hospital, used
specifically for thementally ill from 1402
onwards), the madhouse was the
product of a genuine desire to create
a safe and relatively salubrious environ-
ment for people otherwise exposed to
mistreatment by themselves and others.
Initially, Pinel, Battie, Chiargui, and
other pioneers saw asylums as places
of moral reform rooted in respect and
concern for the patient. Yet, economic
and social pressures, and the inability
of psychiatry to get any positive results,
soon transformed asylums into ware-
houses or mere ‘‘dust bins for hopeless
cases’’, while, not coincidentally,
providing psychiatry with subjects for
therapeutic experimentation. Bloodlet-
ting and purging gave way to psycho-
surgery, shock therapies, and, by the
mid-20th century, psychopharmacol-
ogy, transforming no-hope asylums into
hospitals and giving psychiatry a much-
needed ‘‘lifeline back into mainstream
general medicine’’.
Is this progress? The discipline
of psychiatry may have weathered the
storm of Szasz, Laing and the anti-
psychiatry movement, and in wealthier
countries psychopharmacology may
be reducing the need for institutionali-
zation. But, as Porter remarks, pacifying
patients with drugs hardly seems like
the pinnacle of clinical achievement and,
even today, claims about the maturity
of a science of mental disorders seem
somewhat premature and contestable.
Current trends do not bode well
for the future either. In the last couple
of decades, psychiatry seems to be
shifting its attention to ‘‘milder’’ or
‘‘borderline’’ cases of mental abnorm-
ality (arguably within the range of normal
variability), with a concomitant expan-
sion in complexes and syndromes.
‘‘These days,’’ Porter writes, ‘‘clinics and
techniques for psycho-social problems,
sexual dysfunctions, eating disorders,
and personal relations continue to
proliferate — while prospects are held
out of a pill for every psychological ill.’’
The psychopharmacology industry
is undoubtedly the driving force in this
expansion in the number of mental
disorders and lowering of the threshold
of complaint. One sometimes suspects
that the chemical treatment antedates
the disease and helps to give it an official
existence. Should we not be concerned
about the tendency to use pharmaceu-
tical products to reshape personalities
on the one hand, while creating new and
ever more nuanced varieties of madness
on the other — ‘‘especially when the
development, manufacture, and mar-
keting of such drugs lie in the hands
of monopolistic multinationals’’? One
can only speculate where, but for his
much too early death, these questions
might have taken Porter in his future
writings. n
Jerome E. Bickenbach1
Asbestos blues: labour, capital,
physicians and the state
in South Africa
By Jock McCulloch
Published by James Currey, Oxford, England,
and Indiana University Press, Bloomington,
USA, 2002.
ISBN 0 85255 862 7, price £12.95
The history of asbestos is a remarkable
one of shifting attitudes towards this
substance, from ‘‘magic mineral’’ in the
early days to ‘‘killer dust’’ in the end.
It unfolds as the epidemiological
evidence was slowly compiled, then
concealed, and then, at last, dissemi-
nated. For health professionals interna-
tionally, the rise and fall of asbestos in
South Africa provides a telling account
of short-sightedness, the limits of
human understanding and of science,
and ethical conflict. Given the global
public health importance of asbestos,
there are surprisingly few books on its
history, or on its impact in local contexts,
and perhaps no others at all that
are written with such well-informed
depth of feeling.
McCulloch’s book is a particularly
interesting record of asbestos in one
country, its relation with the interna-
tional industry, and its companies,
workers and communities. It is inspired
by the author’s long-standing interest
in the health of workers and their
communities, and his commitment to
documenting the abuses of power
and information that affect them. The
publisher is a small, radical one, equally
committed to publicizing unusual and
important stories, particularly from
the South. It forms part of a well-
regarded dogma-challenging series
called ‘‘African Issues’’.
Asbestos blues is wide-ranging and
readable, looking at the history of the
1 Professor, Philosophy Department, Queen’s University, Kingston, Ontario, Canada (email: bickenba@post.queensu.ca).
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global industry, the mines, the compa-
nies, the medical history of asbestos, the
difficult lives of the men and women
working in the mines, and the role of the
state. It includes a critical account of
epidemiology in the context of a socially
divided African state with a strong
transnational company presence, offer-
ing valuable insights for anyone with
an interest in the interaction of science
and policy. A particular strength is
in the range of sources the author has
brought together, with primary
interviews, archives and published
books and papers combined to tell a
deeply human story of greed, power —
and courage.
There is some repetition in the book
and it is not for those who like to keep
the world neatly divided into disciplinary
slices. In examining the complex
economic and social processes and their
health outcomes, it encompasses the
real, messy, political world of public
health. In this sense, Asbestos blues tells
a timely and widely relevant public
health story, by documenting the
asbestos background of recent ground-
breaking rulings against transnational
corporations. These may lead to new
powers for communities in the South
to claim due recognition and compensa-
tion for health damage done by
companies working in their countries.
Asbestos blues provides a valuable case
study of how a major harmful industry
falls, and how in this case communities,
unions, epidemiologists, lawyers, public
health professionals and a Southern
state finally came together to work for
public health and social justice. It is
a well-told salutary tale. n
Carolyn Stephens1
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CORRIGENDUM
The following acknowledgement was unintentionally omitted from the paper by Philip Musgrove,
Riadh Zeramdini, & Guy Carrin published on pp.134–142 of Vol. 80, No. 2: ‘‘Thanks are due to
Jean-Pierre Poullier, Patricia Herna´ndez, Chandika Indikadahena and Takondwe Mwase of WHO
for the National Health Accounts estimates, to Peter Heller of the IMF for data on central
government tax structure and expenditures, and to Ke Xu of WHO for the calculations of
catastrophic health expenditure. Discussions with Alan Tait of the WHO Commission on
Macroeconomics and Health and Alex Preker of theWorld Bank, as well as those just named, have
been extremely helpful.’’
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